| |
| |
|
| Insider
Information: |
Xstelos Corp. |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,717,666 |
|
|
Indirect Shares
|
8,033,264 |
|
|
| Direct
Value |
$409,258 |
|
|
|
Indirect Value
|
$159,636 |
|
|
| Total
Shares |
12,750,930 |
|
|
| Total
Value |
$568,893 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 44.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myrexis Inc |
MYRX |
10% Owner |
|
0 |
2013-02-27 |
7,000,000 |
Premium* |
|
|
Enzon Pharmaceuticals Inc |
ENZN |
10% Owner |
2020-03-26 |
4,717,666 |
2020-03-26 |
1,033,264 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-04-13 |
4 |
B |
$0.26 |
$1,222 |
D/D |
4,700 |
3,582,364 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-04-16 |
4 |
B |
$0.26 |
$48,282 |
D/D |
185,700 |
3,768,064 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-02 |
4 |
B |
$0.26 |
$780 |
D/D |
3,000 |
3,771,064 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-07 |
4 |
B |
$0.26 |
$8,710 |
D/D |
33,500 |
3,804,564 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-15 |
4 |
B |
$0.26 |
$14,300 |
D/D |
55,000 |
3,859,564 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-17 |
4 |
B |
$0.26 |
$1,040 |
D/D |
4,000 |
3,863,564 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-18 |
4 |
B |
$0.26 |
$5,252 |
D/D |
20,200 |
3,883,764 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-21 |
4 |
B |
$0.26 |
$13,000 |
D/D |
50,000 |
3,933,764 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-05-22 |
4 |
B |
$0.26 |
$1,430 |
D/D |
5,500 |
3,939,264 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-04 |
4 |
B |
$0.26 |
$260 |
D/D |
1,000 |
3,940,264 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-05 |
4 |
B |
$0.26 |
$520 |
D/D |
2,000 |
3,942,264 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-22 |
4 |
B |
$0.26 |
$17,731 |
D/D |
68,195 |
4,010,459 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-25 |
4 |
B |
$0.26 |
$130 |
D/D |
500 |
4,010,959 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-26 |
4 |
B |
$0.26 |
$291 |
D/D |
1,120 |
4,012,079 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-28 |
4 |
B |
$0.26 |
$8,410 |
D/D |
32,345 |
4,044,424 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-06-29 |
4 |
B |
$0.26 |
$338 |
D/D |
1,300 |
4,045,724 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-02 |
4 |
B |
$0.26 |
$156 |
D/D |
600 |
4,046,324 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-03 |
4 |
B |
$0.26 |
$5,200 |
D/D |
20,000 |
4,066,324 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-05 |
4 |
B |
$0.26 |
$5,714 |
D/D |
21,975 |
4,088,299 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-10 |
4 |
B |
$0.26 |
$728 |
D/D |
2,800 |
4,091,099 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-11 |
4 |
B |
$0.26 |
$165 |
D/D |
635 |
4,091,734 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-20 |
4 |
B |
$0.26 |
$92 |
D/D |
355 |
4,092,089 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-24 |
4 |
B |
$0.26 |
$2,956 |
D/D |
11,368 |
4,103,457 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-26 |
4 |
B |
$0.26 |
$6,930 |
D/D |
26,655 |
4,130,112 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-07-27 |
4 |
B |
$0.26 |
$29 |
D/D |
112 |
4,130,224 |
2.37 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
